Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
19.66
+1.94 (10.95%)
Aug 25, 2026, 3:20 PM EDT - Market open
Generate Biomedicines Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $22 | Buy | Reiterates | $22 | +11.90% | Aug 17, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $24 | Buy | Reiterates | $24 | +22.08% | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +27.16% | Aug 7, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $30 | Buy | Reiterates | $30 | +52.59% | Jun 25, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $26 | Buy | Maintains | $26 | +32.25% | Apr 10, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 24, 2026 |